5. Good riddance, Pam!

Early diagnosis is key to the survival of many ailments, but especially crucial for Naegleria fowleri—aka “brain eating amoeba”—infections called Primary Amebic Meningoencephalitis (PAM), which kill 97% of victims within days. Couple early diagnosis with an effective treatment and that lethal infection isn’t so deadly anymore. This is what doctors at the Florida Hospital for Children in Orlando recently found when treating a 16 year-old patient with Profounda’s drug Impavido (miltefosine), making him the third person to be treated with miltefosine in the US and the fourth person to survive the brain infection caused by the water-born amoeba. Zombies everywhere celebrate job security by swimming in warm, freshwater lakes without plugging their noses.